Stock listing
OTC:AXIM AXIM Biotechnologies, Inc. Stock
Follow AXIM Biotechnologies, Inc. into a list and get an email when it puts out news.
Share price · OTC:AXIM
$0.0031 USD 0.0000 (0.0%)
Close on Nov 20, 2026
- Day range
- $0.0031 – $0.0031 USDNov 20, 2026
- Volume
- 100 sharesNov 20, 2026
- Market cap
- $1.08M USDAt the close on Nov 20, 2026 · price × 349.8M shares outstanding
- 52-week range
- $0.0020 – $0.0290 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $586 USDMedian day 97,217 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:AXIM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0031 | 0.0000 | 0.0% | $0.0031 | $0.0031 | $0.0031 | 100 | |
| $0.0031 | 0.0000 | 0.0% | $0.0031 | $0.0031 | $0.0031 | 10,000 | |
| $0.0031 | 0.0000 | 0.0% | $0.0031 | $0.0032 | $0.0031 | 12,062 | |
| $0.0031 | 0.0000 | 0.0% | $0.0033 | $0.0034 | $0.0031 | 32,579 | |
| $0.0031 | -0.0002 | -6.1% | $0.0031 | $0.0032 | $0.0031 | 136,167 | |
| $0.0033 | +0.0001 | +3.1% | $0.0031 | $0.0033 | $0.0031 | 145,807 | |
| $0.0032 | 0.0000 | 0.0% | $0.0033 | $0.0033 | $0.0032 | 22,319 | |
| $0.0032 | 0.0000 | 0.0% | $0.0033 | $0.0033 | $0.0032 | 101,083 | |
| $0.0032 | -0.0001 | -3.0% | $0.0033 | $0.0033 | $0.0032 | 6,075 | |
| $0.0033 | +0.0001 | +3.1% | $0.0033 | $0.0033 | $0.0033 | 165,000 | |
| $0.0032 | -0.0001 | -3.0% | $0.0032 | $0.0032 | $0.0032 | 44,838 | |
| $0.0033 | +0.0002 | +6.5% | $0.0033 | $0.0033 | $0.0033 | 390,000 | |
| $0.0031 | -0.0001 | -3.1% | $0.0031 | $0.0031 | $0.0031 | 41,000 | |
| $0.0032 | -0.0001 | -3.0% | $0.0032 | $0.0032 | $0.0032 | 100,033 | |
| $0.0033 | +0.0002 | +6.5% | $0.0030 | $0.0033 | $0.0030 | 32,176 | |
| $0.0031 | +0.0001 | +3.3% | $0.0032 | $0.0032 | $0.0031 | 51,150 | |
| $0.0030 | -0.0002 | -6.3% | $0.0030 | $0.0030 | $0.0030 | 12,200 | |
| $0.0032 | +0.0002 | +6.7% | $0.0032 | $0.0032 | $0.0032 | 10,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 1,644 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 248,600 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 373,600 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 46,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 196,300 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 196,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 287,700 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 400,500 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 5,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 200,200 | |
| $0.0030 | -0.0010 | -25.0% | $0.0030 | $0.0040 | $0.0030 | 12,300 | |
| $0.0040 | +0.0005 | +14.3% | $0.0040 | $0.0040 | $0.0040 | 173,700 | |
| $0.0035 | +0.0001 | +2.9% | $0.0034 | $0.0035 | $0.0033 | 166,331 | |
| $0.0034 | +0.0004 | +13.3% | $0.0033 | $0.0034 | $0.0033 | 1,410 | |
| $0.0030 | -0.0010 | -25.0% | $0.0040 | $0.0040 | $0.0030 | 139,400 | |
| $0.0040 | +0.0010 | +33.3% | $0.0030 | $0.0040 | $0.0030 | 75,200 | |
| $0.0030 | -0.0007 | -18.9% | $0.0040 | $0.0040 | $0.0030 | 13,300 | |
| $0.0037 | 0.0000 | 0.0% | $0.0035 | $0.0037 | $0.0033 | 652,606 | |
| $0.0037 | -0.0003 | -7.5% | $0.0037 | $0.0037 | $0.0037 | 40,071 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 300 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 20,500 | |
| $0.0040 | +0.0002 | +5.3% | $0.0030 | $0.0040 | $0.0030 | 238,800 | |
| $0.0038 | +0.0004 | +11.8% | $0.0037 | $0.0038 | $0.0037 | 200 | |
| $0.0034 | -0.0006 | -15.0% | $0.0034 | $0.0034 | $0.0034 | 1,895 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 502,100 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0030 | 152,100 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 80,200 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 1,364,900 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 134,100 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 59,200 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 94,400 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 57,600 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 206,500 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 30,300 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 176,300 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0030 | 629,100 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 192,300 | |
| $0.0040 | +0.0010 | +33.3% | $0.0040 | $0.0040 | $0.0030 | 194,400 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 20,100 | |
| $0.0030 | -0.0003 | -9.1% | $0.0040 | $0.0040 | $0.0030 | 169,000 | |
| $0.0033 | -0.0003 | -8.3% | $0.0035 | $0.0039 | $0.0033 | 451,341 | |
| $0.0036 | +0.0006 | +20.0% | $0.0036 | $0.0036 | $0.0035 | 227,335 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 235,800 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 868,300 |
- Ticker
- OTC:AXIM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease
Latest news
AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease
Oct 6, 2026
Closed $0.0035 (+2.9%) on Oct 6, 2026
AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
Jan 29, 2026
Closed $0.015 (0.0%) on Jan 29, 2026
AXIM Biotechnologies, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 3 in the last 12 months · 184 in all · newest Oct 6, 2026 · oldest 2017
- Decks
- 5 decks · latest January 2022
Valuation
price Nov 20, 2026
- Enterprise value
- No statements on 6ix yet
- P/E
- No statements on 6ix yet
- EV/sales
- No statements on 6ix yet
- EV/EBITDA
- No statements on 6ix yet
- Price/book
- No statements on 6ix yet
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- -0.59
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| AXIM Biotechnologies, Inc. · OTC:AXIM | US$1.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.59 |
| Innovotech Inc. · TSXV:IOT | US$2.66M | US$2.51M | n/a | 1.0× | n/a | 1.5× | −21.1% | 0.1× | 0.39 |
| Qlife Holding AB · OMXSTO:QLIFE | US$2.49M | US$2.88M | n/a | 34.1× | n/a | 9.6× | n/a | 3.1× | n/a |
| Physiomics PLC · LSE:PYC | US$2.46M | US$1.91M | n/a | 1.6× | n/a | 3.6× | −74.1% | 0.0× | n/a |
| 20/20 BioLabs, Inc. · NASDAQ:AIDX | US$2.10M | −US$1.01M | n/a | −0.5× | n/a | 3.4× | −317.8% | 0.9× | 1.41 |
| Bluejay Diagnostics, Inc. · NASDAQ:BJDX | US$1.90M | −US$5.43M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.71 |
| Accustem Sciences Inc · OTC:ACUT | US$1.90M | US$1.88M | n/a | n/a | n/a | n/a | n/a | n/a | 0.19 |
| InVitro International · OTC:IVRO | US$1.87M | US$644,260 | 29.6× | 0.8× | 14.0× | 1.1× | 8.2% | 0.0× | 0.17 |
| Co-Diagnostics, Inc. · NASDAQ:CODX | US$1.36M | US$2.21M | n/a | 2.6× | n/a | 0.1× | n/a | 0.2× | 2.16 |
| Prostatype Genomics AB · OMXSTO:PROGEN | US$1.36M | US$1.32M | n/a | 13.3× | n/a | 2.1× | n/a | 0.0× | n/a |
| Virax Biolabs Group Limited · NASDAQ:VRAX | US$446,402 | −US$5.66M | n/a | −455× | n/a | 0.1× | n/a | 0.1× | 1.38 |
| Median of the others | US$1.90M | US$1.60M | 29.6× | 1.3× | 14.0× | 1.5× | −47.6% | 0.1× | 1.38 |
Team and board
Officers
| Officer | Role |
|---|---|
| Catalina Valencia | Chief Executive Officer/President |
Board
| Director | Role |
|---|---|
| Catalina Valencia | Chief Executive Officer/President |
| Robert Cunningham | Director |
| Timothy R. Scott | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2025 | May 19, 2025 · After close | −1.4% |
| Quarter to Sep 30, 2024 | Nov 18, 2024 · After close | +21.9% |
| Q2 2024 | Aug 19, 2024 · After close | −19.2% |
| Q1 2024 | May 20, 2024 · After close | 0.0% |
| Q3 2023 | Nov 20, 2023 · After close | +2.9% |
| Q2 2023 | Aug 21, 2023 · After close | −20.3% |
| Q4 2023 | May 22, 2023 · After close | +11.7% |
| Q3 2022 | Nov 14, 2022 | −3.6% |
| Q2 2022 | Aug 16, 2022 | −4.1% |
| Q1 2022 | Apr 15, 2022 | −1.9% |
All 14 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2021 | Nov 22, 2021 | −4.8% |
| Q2 2021 | Aug 23, 2021 | −0.6% |
| Q1 2021 | Apr 15, 2021 | +7.5% |
| Q4 2020 | Mar 31, 2021 | +12.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2022) | Investor deck | 25 slides | January 2022 |
| Investor Presentation (July 2021) | Investor deck | 25 slides | July 2021 |
| Investor Presentation (May 2020) | Investor deck | 27 slides | May 2020 |
| Investor Presentation (January 2019) | Investor deck | 13 slides | January 2019 |
| Investor Presentation (June 2017) | Investor deck | 25 slides | June 2017 |
Financials
Annual, in USD
Income statement
| Line | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.5K | 7.40K | 8.88K | 60.5K | 0 | 799.5K | 195.6K | 47.6K | 47.1K | 49.1K |
| Cost of revenue | 0 | 0 | 8.51K | 42.9K | 154.1K | 50.4K | ||||
| Gross profit | 0 | 0 | 187.1K | 4.72K | -107.1K | -1.25K | ||||
| Research and development | 125.5K | 20.3K | 153.7K | 284.9K | 426.7K | 0 | 2.06M | 1.35M | 235.6K | 571.5K |
| Selling, general and administrative | 2.24M | 590.9K | 4.08M | 5.67M | 3.41M | 9.48M | ||||
| Operating income | -2.75M | -710.6K | -4.65M | -14.0M | -4.95M | -3.11M | -5.04M | -3.15M | -3.76M | -10.0M |
| Depreciation and amortization | 427.0K | 106.8K | 426.1K | 2.12M | 16.0K | 3.36K | 3.36K | 3.36K | 3.36K | 1.12K |
| EBITDA | -2.32M | -603.9K | -4.23M | -11.9M | -4.93M | -3.11M | -5.03M | -3.15M | -3.76M | -10.0M |
| Interest expense | 140.0K | 57.8K | 261.5K | 247.8K | 234.8K | 222.2K | 456.1K | 315.0K | 275.7K | 43.2K |
| Income before tax | -8.06M | -2.76M | -6.24M | -16.0M | -6.29M | -2.97M | -6.75M | -4.17M | -5.81M | -10.1M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -8.06M | -2.76M | -6.24M | -16.0M | -6.41M | -6.45M | -6.75M | -4.17M | -5.81M | -10.1M |
| Earnings per share, basic | -0.04 | -0.01 | -0.04 | 0.12 | -0.06 | -0.10 | -0.12 | -0.08 | -0.17 | -0.27 |
| Earnings per share, diluted | -0.04 | -0.01 | -0.04 | 0.12 | -0.06 | -0.10 | -0.12 | -0.08 | -0.17 | -0.27 |
Balance sheet
| Line | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 156.5K | 53.5K | 47.3K | 453.0K | 457.2K | 511.6K | 1.81M | 2.06M | 713.3K | 134.2K |
| Receivables | 0 | 315.8K | 0 | |||||||
| Inventory | 20.1K | 0 | 487.8K | 9.80K | 8.77K | 38.4K | 200.8K | |||
| Current assets | 156.5K | 56.6K | 104.0K | 636.6K | 713.1K | 1.64M | 2.02M | 2.11M | 1.37M | 1.18M |
| Property, plant and equipment | 134.1K | 85.7K | 93.8K | 116.8K | 104.1K | 2.24K | 5.59K | 8.95K | 12.3K | 15.7K |
| Goodwill | 0 | 2.46M | 0 | |||||||
| Total assets | 4.12M | 4.04M | 4.21M | 5.32M | 11.3M | 1.69M | 2.09M | 2.19M | 1.45M | 1.26M |
| Current liabilities | 5.98M | 4.86M | 3.39M | 2.58M | 1.50M | 3.40M | 3.32M | 7.71M | 3.02M | 2.55M |
| Long-term debt | 137.0K | |||||||||
| Total debt | 4.89M | 4.98K | 19.8K | |||||||
| Total liabilities | 11.8M | 10.2M | 9.04M | 7.66M | 9.75M | 8.45M | 8.17M | 8.48M | 3.82M | 2.96M |
| Shareholders' equity | -7.66M | -6.16M | -4.83M | -2.34M | 1.57M | -6.76M | -6.08M | -6.28M | -2.37M | -1.70M |
| Shares outstanding | 245.9M | 223.6M | 192.4M | 138.1M | 125.3M | 64.9M | 59.6M | 54.6M | 52.5M | 39.6M |
Cash flow
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.03M | -2.04M | -2.49M | -3.22M | -5.04M | -4.85M | -3.08M | -1.29M | -1.54M |
| Capital spending | 0 | -8.71K | -40.5K | -97.3K | 0 | -16.8K | |||
| Free cash flow | -1.03M | -2.05M | -2.53M | -3.31M | -1.29M | -1.56M | |||
| Cash from investing | 0 | -8.71K | -50.5K | 9.98K | 348.2K | 0 | 0 | 0 | -16.8K |
| Cash from financing | 1.14M | 1.65M | 2.53M | 3.15M | 3.40M | 4.59M | 4.43M | 1.87M | 1.03M |
| Change in cash | 109.2K | -405.7K | -4.22K | -54.4K | -1.29M | -252.2K | 1.34M | 579.2K | -527.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 15-12G | Dec 5, 2024 | Other filings | SEC |
| NT 10-Q · Late filing notice | Nov 13, 2024 | Explanation request | SEC |
| 4 · Change in ownership | Oct 15, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 15, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 19, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 13, 2024 | Explanation request | SEC |
| 10-Q/A · Quarterly report, amended | May 22, 2024 | Quarterly report | SEC |
| 10-Q · Quarterly report | May 20, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 14, 2024 | Explanation request | SEC |
| 10-K · Annual report | Apr 16, 2024 | Annual report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| NT 10-K · Late filing notice | Apr 1, 2024 | Explanation request | SEC |
| 8-K · Current report | Mar 21, 2024 | Material contract | SEC |
| 4/A · Change in ownership, amended | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 13, 2024 | Material contract | SEC |
| 8-K · Current report | Dec 28, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 20, 2023 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 14, 2023 | Explanation request | SEC |
| DEF 14C | Sep 21, 2023 | Meeting notice | SEC |
| PRE 14C | Aug 31, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 21, 2023 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2023 | Explanation request | SEC |
| EFFECT · Notice that a registration is effective | Jun 12, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 7, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 7, 2023 | Other filings | SEC |
| S-1 · Registration statement | Jun 2, 2023 | Offer document | SEC |
| 8-K · Current report | Jun 2, 2023 | Material contract | SEC |
| 8-K · Current report | May 30, 2023 | Material contract | SEC |
| 3 · Initial statement of ownership | May 30, 2023 | Insider trade | SEC |
| 8-K · Current report | May 25, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | May 22, 2023 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2023 | Explanation request | SEC |
| 10-K · Annual report | Apr 17, 2023 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 30, 2023 | Explanation request | SEC |
| 8-K · Current report | Jan 27, 2023 | Material contract | SEC |
| 10-Q/A · Quarterly report, amended | Nov 15, 2022 | Quarterly report | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 144 · Notice of proposed sale | Oct 7, 2022 | Other filings | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2022 | Insider trade | SEC |
| SC 13D · Big-stake notice | Sep 23, 2022 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Sep 23, 2022 | Insider trade | SEC |
| 8-K · Current report | Sep 19, 2022 | Material contract | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 31, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 31, 2022 | Insider trade | SEC |
| SC 13D · Big-stake notice | Aug 31, 2022 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Aug 31, 2022 | Insider trade | SEC |
| SC 13D · Big-stake notice | Aug 31, 2022 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Aug 31, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 29, 2022 | Material contract | SEC |
| 4 · Change in ownership | Aug 26, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 16, 2022 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 15, 2022 | Explanation request | SEC |
| EFFECT · Notice that a registration is effective | Aug 5, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 2, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 1, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jul 29, 2022 | Other filings | SEC |
| S-1 · Registration statement | Jul 22, 2022 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Jun 14, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | May 23, 2022 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 16, 2022 | Explanation request | SEC |
| 10-K/A · Annual report, amended | Apr 19, 2022 | Annual report | SEC |
| 10-K · Annual report | Apr 15, 2022 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2022 | Explanation request | SEC |
| 8-K · Current report | Mar 9, 2022 | Current report | SEC |
| 8-K · Current report | Feb 16, 2022 | Material contract | SEC |
| 4 · Change in ownership | Feb 15, 2022 | Insider trade | SEC |
| 8-K · Current report | Jan 11, 2022 | Management or board change | SEC |
| 8-K · Current report | Jan 7, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 22, 2021 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 15, 2021 | Explanation request | SEC |
| 10-Q · Quarterly report | Aug 23, 2021 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 13, 2021 | Explanation request | SEC |
| 8-K · Current report | Aug 3, 2021 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Jun 23, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 21, 2021 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 9, 2021 | Offer document | SEC |
| 10-Q/A · Quarterly report, amended | Jun 1, 2021 | Quarterly report | SEC |
| 10-Q · Quarterly report | May 24, 2021 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | May 19, 2021 | Other filings | SEC |
| NT 10-Q · Late filing notice | May 14, 2021 | Explanation request | SEC |
| S-1 · Registration statement | May 14, 2021 | Offer document | SEC |
| 8-K · Current report | May 14, 2021 | Material contract | SEC |
| 10-K/A · Annual report, amended | Apr 26, 2021 | Annual report | SEC |
| 10-K · Annual report | Apr 15, 2021 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 30, 2021 | Explanation request | SEC |
| 10-Q/A · Quarterly report, amended | Nov 25, 2020 | Quarterly report | SEC |
| 10-Q · Quarterly report | Nov 20, 2020 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 13, 2020 | Explanation request | SEC |
| 10-Q/A · Quarterly report, amended | Aug 18, 2020 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 14, 2020 | Quarterly report | SEC |
| 8-K · Current report | Jul 23, 2020 | Management or board change | SEC |
| 10-Q/A · Quarterly report, amended | Jul 2, 2020 | Quarterly report | SEC |
| 10-Q · Quarterly report | Jun 29, 2020 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Jun 29, 2020 | Explanation request | SEC |
| D | Jun 12, 2020 | Other filings | SEC |
| 8-K/A · Current report, amended | May 28, 2020 | Current report | SEC |
| 10-K/A · Annual report, amended | May 19, 2020 | Annual report | SEC |
| 8-K · Current report | May 14, 2020 | Current report | SEC |
| 10-K · Annual report | May 14, 2020 | Annual report | SEC |
| 8-K · Current report | May 12, 2020 | Current report | SEC |
| 8-K · Current report | May 12, 2020 | Acquisition or disposal | SEC |
| 8-K · Current report | Mar 27, 2020 | Current report | SEC |
| 8-K · Current report | Mar 18, 2020 | Acquisition or disposal | SEC |
| UPLOAD · Letter from the SEC | Jan 10, 2020 | Other filings | SEC |
| 8-K · Current report | Jan 8, 2020 | Material contract | SEC |
| CORRESP · Letter to the SEC | Dec 23, 2019 | Other filings | SEC |
| 8-K · Current report | Dec 16, 2019 | Material contract | SEC |
| 424B5 · Prospectus | Dec 16, 2019 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Nov 25, 2019 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 14, 2019 | Quarterly report | SEC |
| CORRESP · Letter to the SEC | Oct 29, 2019 | Other filings | SEC |
| 10-K/A · Annual report, amended | Oct 29, 2019 | Annual report | SEC |
| UPLOAD · Letter from the SEC | Oct 23, 2019 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 14, 2019 | Quarterly report | SEC |
| 8-K · Current report | Jul 9, 2019 | Material contract | SEC |
| 8-K · Current report | Jun 3, 2019 | Material contract | SEC |
| 10-Q · Quarterly report | May 15, 2019 | Quarterly report | SEC |
| 8-K · Current report | Apr 23, 2019 | Material contract | SEC |
| 10-K · Annual report | Apr 8, 2019 | Annual report | SEC |
| 8-K · Current report | Apr 4, 2019 | Management or board change | SEC |
| NT 10-K · Late filing notice | Mar 29, 2019 | Explanation request | SEC |
| 8-K · Current report | Feb 26, 2019 | Current report | SEC |
| 8-K · Current report | Jan 15, 2019 | Current report | SEC |
| 8-K · Current report | Jan 8, 2019 | Management or board change | SEC |
| 8-K · Current report | Dec 7, 2018 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2018 | Quarterly report | SEC |
| 8-K · Current report | Sep 13, 2018 | Material contract | SEC |
| 8-K · Current report | Aug 27, 2018 | Material contract | SEC |
| 10-Q/A · Quarterly report, amended | Aug 17, 2018 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 14, 2018 | Quarterly report | SEC |
| D | May 18, 2018 | Other filings | SEC |
| 10-Q/A · Quarterly report, amended | May 17, 2018 | Quarterly report | SEC |
| 10-Q · Quarterly report | May 14, 2018 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2018 | Material contract | SEC |
| 8-K · Current report | Apr 18, 2018 | Material contract | SEC |
| 424B5 · Prospectus | Apr 18, 2018 | Offer document | SEC |
| 4 · Change in ownership | Apr 6, 2018 | Insider trade | SEC |
| 8-K · Current report | Apr 5, 2018 | Material contract | SEC |
| 10-K · Annual report | Mar 15, 2018 | Annual report | SEC |
| 10-Q · Quarterly report | Nov 20, 2017 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 14, 2017 | Explanation request | SEC |
| EFFECT · Notice that a registration is effective | Sep 15, 2017 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 14, 2017 | Other filings | SEC |
| 10-Q/A · Quarterly report, amended | Sep 14, 2017 | Quarterly report | SEC |
| 10-Q/A · Quarterly report, amended | Sep 14, 2017 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | Sep 14, 2017 | Annual report | SEC |
| UPLOAD · Letter from the SEC | Sep 14, 2017 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 11, 2017 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 6, 2017 | Other filings | SEC |
| S-3 · Registration statement | Aug 24, 2017 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 21, 2017 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2017 | Explanation request | SEC |
| 3 · Initial statement of ownership | Jun 23, 2017 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 23, 2017 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 23, 2017 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 23, 2017 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 23, 2017 | Insider trade | SEC |
| 8-K/A · Current report, amended | Jun 23, 2017 | Material contract | SEC |
| 8-K · Current report | Jun 16, 2017 | Material contract | SEC |
| 10-Q · Quarterly report | May 22, 2017 | Quarterly report | SEC |
| 8-K · Current report | May 16, 2017 | Current report | SEC |
| NT 10-Q · Late filing notice | May 16, 2017 | Explanation request | SEC |
| 8-K · Current report | May 15, 2017 | Current report | SEC |
| 10-K/A · Annual report, amended | Apr 19, 2017 | Annual report | SEC |
| 10-K · Annual report | Apr 17, 2017 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2017 | Explanation request | SEC |
| 8-K · Current report | Mar 28, 2017 | Current report | SEC |
| 8-K · Current report | Mar 22, 2017 | Current report | SEC |
| 5/A · Annual statement of ownership, amended | Feb 28, 2017 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 28, 2017 | Big-stake notice | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 28, 2017 | Big-stake notice | SEC |
| 5 · Annual statement of ownership | Feb 15, 2017 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 15, 2017 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 15, 2017 | Insider trade | SEC |
| 8-K · Current report | Jan 18, 2017 | Current report | SEC |
| 8-K · Current report | Jan 10, 2017 | Current report | SEC |
| 8-K · Current report | Dec 29, 2016 | Current report | SEC |
| 8-K · Current report | Dec 13, 2016 | Current report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 29, 2016 | Quarterly report | SEC |
| 10-Q · Quarterly report | Nov 21, 2016 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 14, 2016 | Explanation request | SEC |
| 10-Q/A · Quarterly report, amended | Aug 25, 2016 | Quarterly report | SEC |
This page holds 200 of 306 filings. Open Filings
Cap table
Built by 6ix from AXIM Biotechnologies, Inc.’s releases
- Common shares
- 349,804,452
- Fully diluted
- 349,804,452
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 349,804,452 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 349,804,452 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John Walter Huemoeller II Other companies: Pledge Petroleum Corp (Director · May 2, 2018 – May 2, 2018 · Past) | Chief Executive Officer, Director · May 18, 2017 – Mar 15, 2024 · Past |
| Lekhram Changoer Other companies: Incannex Healthcare Inc. (Chief Technology Officer · Since at least Nov 28, 2023) | Director · Apr 23, 2015 – Dec 31, 2016 · Past |
| Robert Malasek Other companies: Neuropathix Inc (Director · Mar 12, 2021 – Mar 12, 2021 · Past) | Chief Financial Officer · Sep 23, 2022 – Mar 15, 2024 · Past |
| Timothy R. Scott Other companies: Neuropathix Inc (Director · Mar 12, 2021 – Mar 12, 2021 · Past) | Director · Since at least May 18, 2017 |
| Blake Schroeder | Director · Aug 22, 2022 – Mar 15, 2024 · Past |
| Catalina Valencia | Chief Executive Officer/President · Since at least Jan 30, 2024 |
| Kurt Phinney | Chief Operating Officer · May 23, 2023 – May 23, 2023 · Past |
| Robert Cunningham | Director · Since at least Sep 23, 2022 |
Log in to ask 6ix AI your own questions about AXIM Biotechnologies, Inc.